Live Breaking News & Updates on Takeda ventures

Stay informed with the latest breaking news from Takeda ventures on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Takeda ventures and stay connected to the pulse of your community

Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair

Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , Toronto , Ontario , Canada , Jan-thirkettle , Sylvie-berrebi , Frazer-hall , Meenu-chhabra-karson , Chhabra-karson , Vp-business-development

Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cambridge , Cambridgeshire , United-kingdom , United-states , American , David-rawlings , Richard-james , Monika-musial-siwek , Protein-sciences , Bristol-myers-squibb , Longwood-fund , Linkedin

MaxCyte Signs Strategic Platform License with Be Biopharma

Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs...

United-kingdom , Anya-bolshem , Chris-welsh , Maher-masoud , David-deuchler , Bio-bcms , Richard-james , Panmure-gordon , Mary-jane-elliott , Emma-earl-freddy-crossley , Rupert-dearden , David-rawlings

Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization

Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Cambridge , Cambridgeshire , United-kingdom , American , Angus-smith , Los-angeles , Joanne-smith-farrell , David-rawlings , Richard-james , Atlas-venture , Bristol-myers-squibb

Be Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Be Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

San-francisco , California , United-states , Joanne-smith-farrell , David-rawlings , Richard-james , Linkedin , Be-biopharma-inc , Seattle-children-research-institute , Longwood-fund , Atlas-venture , Bristol-myers-squibb

EvolveImmune Therapeutics Provides Corporate and Program Update Highlighted by Closing of $37 Million Financing

EvolveImmune Therapeutics Provides Corporate and Program Update Highlighted by Closing of $37 Million Financing
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Tim-brons , Stephen-bloch , Takeda-ventures-inc , Evolveimmune-therapeutics-inc , Bristol-myers-squibb , Engager-program , Fundraising-includes-strategic-investment , Bristol-myers-squibb-coupled , Immune-initiates-chemistry , Lead-multi-functionalt-cell-engager-program , Following-presentation

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B​

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B​
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , San-diego , California , American , Richarda-morgan , Richard-james , Joanne-smith-farrell , David-rawlings , Richard-morgan , S-centers-for-disease , Blood-products-advisory-committee , Bristol-myers-squibb

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-1

BE-101 is Company’s Lead Program in Hemophilia B; IND Filing Anticipated in Mid-2024Be Bio Appoints Glenn Pierce, M.D., Ph.D., Hemophilia Physician-Researcher and Advocate, to its Scientific Advisory BoardPreclinical Study Findings Shared in Oral Presentation During 65th Annual Meeting of the American Society of Hem...

San-diego , California , United-states , American , Richarda-morgan , David-rawlings , Richard-james , Joanne-smith-farrell , Bristol-myers-squibb , Us-department-of-health , Hemophiliab-national-bleeding-disorders-foundation , Drug-administration